CN112274584A - Medicinal preparation for treating diabetic foot wound - Google Patents

Medicinal preparation for treating diabetic foot wound Download PDF

Info

Publication number
CN112274584A
CN112274584A CN202011223419.5A CN202011223419A CN112274584A CN 112274584 A CN112274584 A CN 112274584A CN 202011223419 A CN202011223419 A CN 202011223419A CN 112274584 A CN112274584 A CN 112274584A
Authority
CN
China
Prior art keywords
diabetic foot
treating diabetic
raw materials
radix
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011223419.5A
Other languages
Chinese (zh)
Inventor
王艳艳
冯继东
李瑞恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202011223419.5A priority Critical patent/CN112274584A/en
Publication of CN112274584A publication Critical patent/CN112274584A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/808—Scrophularia (figwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicinal preparation for treating diabetic foot wounds, which is prepared from the following raw materials in parts by mass: 20-40g of astragalus membranaceus, 20-40g of Chinese yam, 20-40g of radix puerariae, 4-8g of rhizoma atractylodis, 6-10g of bighead atractylodes rhizome, 50-70g of trichosanthes root, 10-18g of radix scrophulariae, 15-22g of poria cocos, 25-35g of radix rehmanniae, 20-40g of gypsum, 15-35g of cortex moutan, 15-30g of lotus stamen, 26-34g of pollen, 24-34g of keel, 26-34g of oyster, 16-24g of fructus lycii, 12-18g of cornus officinalis and 8-12g of schisandra chinensis.

Description

Medicinal preparation for treating diabetic foot wound
Technical Field
The invention relates to the technical field of medicines, in particular to a medicinal preparation for treating diabetic foot wounds.
Background
The diabetic foot refers to the pathological changes of foot pain, foot ulcer, foot gangrene and the like caused by diabetic neuropathy, including peripheral nerve sensory disturbance and vegetative nerve damage, vascular disease of lower limbs, namely arteriosclerosis, or skin microangiopathy and bacterial infection. Often due to a synergy of three factors, ischemia, neuropathy and infection. The existing diabetes medicine is commonly used with western medicines, and other side effects are easy to occur. Therefore, the invention provides a medicinal preparation for treating diabetic foot wounds.
Disclosure of Invention
The invention aims to provide a medicinal preparation for treating diabetic foot wounds, which aims to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme:
a medicinal preparation for treating diabetic foot wounds comprises the following raw materials in parts by mass: 20-40g of astragalus membranaceus, 20-40g of Chinese yam, 20-40g of radix puerariae, 4-8g of rhizoma atractylodis, 6-10g of bighead atractylodes rhizome, 50-70g of radix trichosanthis, 10-18g of radix scrophulariae, 15-22g of poria cocos, 25-35g of radix rehmanniae, 20-40g of gypsum, 15-35g of cortex moutan, 15-30g of lotus stamen, 26-34g of pollen, 24-34g of keel, 26-34g of oyster, 16-24g of fructus lycii, 12-18g of sweet potato meat and 8-12g of schisandra chinensis.
As a further scheme of the invention: the pharmaceutical preparation is prepared from the following raw materials in parts by mass: 20g of astragalus membranaceus, 20g of Chinese yam, 20g of kudzuvine root, 4g of rhizoma atractylodis, 6g of bighead atractylodes rhizome, 50g of trichosanthes root, 10g of radix scrophulariae, 15g of poria cocos, 25g of rehmannia root, 20g of gypsum, 15g of cortex moutan, 15g of stamen nelumbinis, 26g of pollen, 26g of oyster, 16g of wolfberry fruit, 12g of cornus fruit and 8g of schisandra chinensis.
As a still further scheme of the invention: the preparation method of the pharmaceutical preparation comprises the following specific steps:
step (1): weighing raw materials according to the parts by weight, adding 1500-2000ml of water into the weighed raw materials, and soaking for 30-40 minutes;
step (2): decocting the raw materials soaked in the step (1) with small fire until boiling, and then decocting for 20-30 minutes;
and (3): filtering the mixture obtained in the step (2) to obtain liquid medicine;
and (4): and (4) cooling the filtered liquid medicine obtained in the step (3), and bottling and storing.
As a still further scheme of the invention: the water adding amount in the step (1) is 1500 ml.
As a still further scheme of the invention: the soaking time in the step (1) is 30 minutes.
As a still further scheme of the invention: the cooking time after boiling in the step (2) is 20 minutes.
The medicine of the invention has the following properties:
radix astragali is root of Astragalus membranaceus bge of Leguminosae. Digging in spring and autumn, removing soil, fibrous roots and root heads, drying in the sun until the root is six and seven dry, straightening, bundling and drying in the sun, and the main functions are as follows: invigorating qi, consolidating superficial resistance, expelling toxin, expelling pus, promoting urination, and promoting granulation, and can be used for treating qi deficiency, asthenia, chronic diarrhea, rectocele, spontaneous perspiration, edema, uterine prolapse, chronic nephritis, albuminuria, diabetes, and unhealed wound.
The rhizoma Dioscoreae tuber is rich in starch, can be used for vegetable food, and can be used as medicine for invigorating spleen and stomach deficiency, and treating deficiency of qi, asthenia, dyspepsia, nocturnal emission, enuresis and innominate toxic swelling.
Radix Puerariae is dried root of Pueraria lobata Ohwi of Leguminosae, called Pueraria lobata Ohwi, collected in autumn and winter, and cut into thick slices or small pieces when it is fresh; and (5) drying. Sweet, pungent and cool, with the actions of relieving muscles and fever, promoting eruption, promoting the production of body fluid to quench thirst, and invigorating yang to arrest diarrhea, it is commonly used for exterior syndrome fever, stiffness and pain of neck and back, measles without adequate eruption, fever thirst, yin deficiency to quench thirst, heat diarrhea and dysentery, and spleen deficiency to purge.
Rhizoma Atractylodis is used for treating damp obstruction of middle warmer, abdominal distention, diarrhea, edema, tinea pedis, flaccidity cramped, rheumatalgia, wind-cold type common cold, night blindness, dim eyesight, and unsmooth vision.
Bighead atractylodes rhizome, rhizoma Atractylodis Macrocephalae, with its medicinal function of activating the spleen, is bitter, warm, pungent and strong in property and taste, and has the actions of drying dampness, resolving turbidity and relieving pain.
The trichosanthes root is the root of trichosanthes kirilowii maxim of Cucurbitaceae, is a traditional Chinese medicine, is a heat-clearing and fire-purging medicine, has the specific effects of clearing heat and purging fire, promoting the production of body fluid to quench thirst, expelling pus and reducing swelling, and mainly treats the following symptoms: it is used to treat thirst, diabetes, jaundice, lung dryness, hemoptysis, carbuncle, swelling, and hemorrhoid flaccidity. For treating diabetes, it is often used in combination with yin-nourishing herbs to achieve the effect of treating both principal and secondary aspect of disease.
Radix scrophulariae has sweet, bitter, salty and slightly cold nature, and has effects of clearing heat and cooling blood, nourishing yin and lowering fire, removing toxic substance and resolving hard mass.
Poria is used for treating edema, oliguria, phlegm-fluid retention, dizziness, palpitation, spleen deficiency, anorexia, loose stool, diarrhea, uneasiness, palpitation, and insomnia.
Rehmannia is cool in nature and sweet and bitter in taste, and has the effects of nourishing yin, tonifying kidney, nourishing blood, enriching blood and cooling blood. It is beneficial for patients with yin deficiency, blood deficiency and kidney deficiency, and rehmanniae radix has effects of tonifying heart, promoting urination, relieving fever, relieving inflammation, promoting blood coagulation and reducing blood sugar.
The plaster stone is mainly used for treating apoplexy with cold and heat, and has the functions of relieving muscles and sweating, removing dry mouth and tongue, headache and toothache and the like.
Cortex moutan, also called cortex moutan, is dried root bark of Paeonia suffruticosa of Ranunculaceae, collected in autumn, removed fine root, stripped root bark, sun-dried, unprocessed or parched, modern research shows that paeonol and other glycosides have antiinflammatory effect; the methanol extract of cortex moutan has platelet inhibiting effect; paeonol has central inhibitory effect on tranquilizing mind, lowering temperature, relieving fever, relieving pain, relieving spasm, etc., and has effects of resisting atherosclerosis, diuresis, and ulcer.
Lotus stamen has the effects of reinforcing kidney and arresting seminal emission, and is commonly used for spermatorrhea, leukorrhagia and frequent micturition.
The pollen is rich in amino acids, vitamin A, vitamin C, vitamin E, active substances, trace elements selenium, phospholipid, nucleic acid, etc.
The oyster extract can effectively prevent and treat bone metabolism disorder caused by prednisone, and can improve the contents of bone calcium, bone phosphorus, bone zinc and bone iron of rats, so that the reduction of blood calcium can be recovered to be normal.
Fructus Lycii has effects of nourishing liver and kidney, replenishing vital essence, and improving eyesight.
Corni fructus can be used for treating giddiness, tinnitus, soreness of waist and knees, sexual impotence, spermatorrhea, enuresis, frequent micturition, metrorrhagia, leukorrhagia, and hyperhidrosis.
Schisandra chinensis has the effects of astringing lung, nourishing kidney, promoting fluid production, arresting sweating and controlling nocturnal emission. It can be used for treating lung deficiency, asthma, cough, xerostomia, thirst, spontaneous perspiration, night sweat, fatigue, marasmus, nocturnal emission, chronic diarrhea, and chronic dysentery.
Compared with the prior art, the invention has the beneficial effects that:
the medicinal preparation is convenient to use, has no toxic or side effect, can effectively promote the blood circulation of skin and the metabolism function of skin cells, and promotes the healing and rehabilitation of foot wound surfaces.
Detailed Description
The technical solution of the present invention will be described in further detail with reference to specific embodiments.
Example 1
A medicinal preparation for treating diabetic foot wounds comprises the following raw materials in parts by mass: 20g of astragalus membranaceus, 20g of Chinese yam, 20g of kudzuvine root, 4g of rhizoma atractylodis, 6g of bighead atractylodes rhizome, 50g of trichosanthes root, 10g of radix scrophulariae, 15g of poria cocos, 25g of rehmannia root, 20g of gypsum, 15g of cortex moutan, 15g of stamen nelumbinis, 26g of pollen, 26g of oyster, 16g of wolfberry fruit, 12g of cornus fruit and 8g of schisandra chinensis.
The preparation method of the pharmaceutical preparation comprises the following specific steps:
step (1): weighing raw materials according to the parts by weight, adding 1500ml of water into the weighed raw materials, and soaking for 30 minutes;
step (2): decocting the raw materials soaked in the step (1) with small fire until boiling, and then decocting for 20 minutes;
and (3): filtering the mixture obtained in the step (2) to obtain liquid medicine;
and (4): and (4) cooling the filtered liquid medicine obtained in the step (3), and bottling and storing.
Example 2
A medicinal preparation for treating diabetic foot wounds comprises the following raw materials in parts by mass: 30g of astragalus membranaceus, 30g of Chinese yam, 30g of kudzuvine root, 6g of rhizoma atractylodis, 8g of bighead atractylodes rhizome, 60g of trichosanthes root, 14g of radix scrophulariae, 20g of poria cocos, 30g of radix rehmanniae, 30g of gypsum, 25g of cortex moutan, 22g of stamen nelumbinis, 30g of pollen, 30g of keel, 30g of oyster, 20g of wolfberry fruit, 16g of sweet potato meat and 10g of schisandra chinensis.
The preparation method of the pharmaceutical preparation comprises the following specific steps:
step (1): weighing raw materials according to the parts by weight, adding 2000ml of water into the weighed raw materials, and soaking for 35 minutes;
step (2): decocting the raw materials soaked in the step (1) with small fire until boiling, and then decocting for 25 minutes;
and (3): filtering the mixture obtained in the step (2) to obtain liquid medicine;
and (4): and (4) cooling the filtered liquid medicine obtained in the step (3), and bottling and storing.
Example 3
A medicinal preparation for treating diabetic foot wounds comprises the following raw materials in parts by mass: 40g of astragalus, 40g of Chinese yam, 40g of kudzuvine root, 8g of rhizoma atractylodis, 10g of largehead atractylodes rhizome, 70g of mongolian snakegourd root, 18g of figwort root, 22g of tuckahoe, 35g of rehmannia root, 40g of gypsum, 35g of cortex moutan, 30g of lotus stamen, 34g of pollen, 34g of oyster, 24g of medlar, 18g of cornus officinalis and 12g of Chinese magnoliavine fruit.
The preparation method of the pharmaceutical preparation comprises the following specific steps:
step (1): weighing raw materials according to the parts by weight, adding 2000ml of water into the weighed raw materials, and soaking for 40 minutes;
step (2): decocting the raw materials soaked in the step (1) with small fire until boiling, and then decocting for 30 minutes;
and (3): filtering the mixture obtained in the step (2) to obtain liquid medicine;
and (4): and (4) cooling the filtered liquid medicine obtained in the step (3), and bottling and storing.
The using method comprises the following steps: the foot wound surface is disinfected, exudate of the foot wound surface is drained, necrotic tissues are removed, the medicine is uniformly coated on the foot wound surface, and the foot wound surface is protected by applying the medicine once and wrapping a layer with gauze.
While the preferred embodiments of the present invention have been described in detail, the present invention is not limited to the above embodiments, and various changes can be made without departing from the spirit of the present invention within the knowledge of those skilled in the art.

Claims (6)

1. The medicinal preparation for treating diabetic foot wounds is characterized by comprising the following raw materials in parts by mass: 20-40g of astragalus membranaceus, 20-40g of Chinese yam, 20-40g of radix puerariae, 4-8g of rhizoma atractylodis, 6-10g of bighead atractylodes rhizome, 50-70g of radix trichosanthis, 10-18g of radix scrophulariae, 15-22g of poria cocos, 25-35g of radix rehmanniae, 20-40g of gypsum, 15-35g of cortex moutan, 15-30g of lotus stamen, 26-34g of pollen, 24-34g of keel, 26-34g of oyster, 16-24g of fructus lycii, 12-18g of sweet potato meat and 8-12g of schisandra chinensis.
2. The pharmaceutical preparation for treating diabetic foot wounds according to claim 1 is characterized by being composed of the following raw materials in parts by mass: 20g of astragalus membranaceus, 20g of Chinese yam, 20g of kudzuvine root, 4g of rhizoma atractylodis, 6g of bighead atractylodes rhizome, 50g of trichosanthes root, 10g of radix scrophulariae, 15g of poria cocos, 25g of rehmannia root, 20g of gypsum, 15g of cortex moutan, 15g of stamen nelumbinis, 26g of pollen, 26g of oyster, 16g of wolfberry fruit, 12g of cornus fruit and 8g of schisandra chinensis.
3. The pharmaceutical preparation for treating diabetic foot wounds according to any one of claims 1 to 2, which is prepared by the following specific steps:
step (1): weighing raw materials according to the parts by weight, adding 1500-2000ml of water into the weighed raw materials, and soaking for 30-40 minutes;
step (2): decocting the raw materials soaked in the step (1) with small fire until boiling, and then decocting for 20-30 minutes;
and (3): filtering the mixture obtained in the step (2) to obtain liquid medicine;
and (4): and (4) cooling the filtered liquid medicine obtained in the step (3), and bottling and storing.
4. The pharmaceutical preparation for treating diabetic foot wounds according to claim 3, wherein the amount of water added in the step (1) is 1500 ml.
5. The pharmaceutical preparation for treating diabetic foot wounds according to claim 3, wherein the soaking time in the step (1) is 30 minutes.
6. The pharmaceutical preparation for treating diabetic foot wounds according to claim 3, wherein the boiling-followed re-boiling time in the step (2) is 20 minutes.
CN202011223419.5A 2020-11-05 2020-11-05 Medicinal preparation for treating diabetic foot wound Pending CN112274584A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011223419.5A CN112274584A (en) 2020-11-05 2020-11-05 Medicinal preparation for treating diabetic foot wound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011223419.5A CN112274584A (en) 2020-11-05 2020-11-05 Medicinal preparation for treating diabetic foot wound

Publications (1)

Publication Number Publication Date
CN112274584A true CN112274584A (en) 2021-01-29

Family

ID=74352204

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011223419.5A Pending CN112274584A (en) 2020-11-05 2020-11-05 Medicinal preparation for treating diabetic foot wound

Country Status (1)

Country Link
CN (1) CN112274584A (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
复禾健康: "糖尿病足的中医辨证治疗", 《HTTPS://DISE.FH21.COM.CN/ARTICLE/DETAIL/7405.HTML》 *

Similar Documents

Publication Publication Date Title
CN110141644A (en) A kind of pharmaceutical composition for improving eyesight and preparation method thereof and purposes
CN103908633A (en) Chinese herbal preparation for treating ovarian cyst
CN103071028A (en) Traditional Chinese medicinal composition for treating anaphylactoid purpura
CN102920981A (en) Traditional Chinese medicine for treating hepatorenal syndrome
CN107715014A (en) A kind of Chinese medicine composition for gout and preparation method thereof
CN106177495A (en) Chinese medicine composition for the treatment of diabetes and preparation method thereof
CN104984265A (en) Traditional Chinese medicine preparation for cutaneous hemangioma and preparation method thereof
CN104083591B (en) A kind of external stype and preparation method for the treatment of hemorrhoid
CN103893521A (en) Traditional Chinese medicine for treating chronic gastritis and preparation method thereof
CN104083576A (en) Traditional Chinese medicine for treating skin ulcer and preparation method of traditional Chinese medicine
CN104940752B (en) A kind of Chinese medicine preparation and preparation method thereof for treating ulcus vulvae
CN103908543A (en) Traditional Chinese medicine for treating sequelae of apoplexy and preparation method thereof
CN112274584A (en) Medicinal preparation for treating diabetic foot wound
CN103041112B (en) Traditional Chinese medicine for treating simple obesity fatty liver
CN105327181A (en) Medicine composition for treating diabetes
CN100421706C (en) Chinese medicinal composition for treating climacteric syndrome and its preparation method
CN110840981A (en) Medicine for treating lumbar prolapse and preparation method thereof
CN110193076A (en) A kind of Chinese medicine composition and preparation for treating hypertension, hyperlipidemia, high blood viscosity
CN111166825A (en) Medicine for treating early hypertension yin deficiency stroke hemiplegia and preparation method thereof
CN104971340B (en) A kind of Chinese medicine preparation and preparation method thereof for treating diarrhea associated with menstruation
CN103330833B (en) Traditional Chinese medicine for treating great occipital neuralgia
CN111840497B (en) Medicine for treating scars and preparation method thereof
CN104587416A (en) Traditional Chinese medicinal composition for treating early hepatocirrhosis
CN118078885A (en) Externally applied medicine containing radix notoginseng for treating arthralgia
CN104873854A (en) Traditional Chinese medicine preparation for rteriolar nephrosclerosis and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210129

RJ01 Rejection of invention patent application after publication